[
  {
    "ts": null,
    "headline": "Amgen (AMGN) Earnings Expected to Grow: Should You Buy?",
    "summary": "Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
    "url": "https://finnhub.io/api/news?id=780d54fa48a3db64907c45aa03add9cb392b36f16c9864334ed8e8b4fae78dad",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745503295,
      "headline": "Amgen (AMGN) Earnings Expected to Grow: Should You Buy?",
      "id": 134067635,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.",
      "url": "https://finnhub.io/api/news?id=780d54fa48a3db64907c45aa03add9cb392b36f16c9864334ed8e8b4fae78dad"
    }
  },
  {
    "ts": null,
    "headline": "1 Value Stock to Research Further and 2 to Ignore",
    "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
    "url": "https://finnhub.io/api/news?id=b998c672bf1a24cee85ac6ef410516a781a108a56bc2acfcc3172f248c1ebbae",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745499714,
      "headline": "1 Value Stock to Research Further and 2 to Ignore",
      "id": 134067636,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Value stocks typically trade at discounts to the broader market, offering patient investors the opportunity to buy businesses when they’re out of favor. The key risk, however, is that these stocks are usually cheap for a reason – five cents for a piece of fruit may seem like a great deal until you find out it’s rotten.",
      "url": "https://finnhub.io/api/news?id=b998c672bf1a24cee85ac6ef410516a781a108a56bc2acfcc3172f248c1ebbae"
    }
  },
  {
    "ts": null,
    "headline": "Johnson & Johnson Just Proved The Bears Wrong Again",
    "summary": "Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain bullish on JNJ stock.",
    "url": "https://finnhub.io/api/news?id=57aa4cff71446c393dbf92bb5ecae722b966749d477e71cda454ed310acd9580",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1745480800,
      "headline": "Johnson & Johnson Just Proved The Bears Wrong Again",
      "id": 134058686,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1146642361/image_1146642361.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "Johnson & Johnson has started 2025 better than I expected, even with the long-running talc saga. Find out why I remain bullish on JNJ stock.",
      "url": "https://finnhub.io/api/news?id=57aa4cff71446c393dbf92bb5ecae722b966749d477e71cda454ed310acd9580"
    }
  }
]